MethMarker: User-friendly design and optimization of gene-specific DNA methylation assays

Max-Planck-Institut für Informatik, Saarbrücken, Germany.
Genome biology (Impact Factor: 10.81). 10/2009; 10(10):R105. DOI: 10.1186/gb-2009-10-10-r105
Source: PubMed


DNA methylation is a key mechanism of epigenetic regulation that is frequently altered in diseases such as cancer. To confirm the biological or clinical relevance of such changes, gene-specific DNA methylation changes need to be validated in multiple samples. We have developed the MethMarker software to help design robust and cost-efficient DNA methylation assays for six widely used methods. Furthermore, MethMarker implements a bioinformatic workflow for transforming disease-specific differentially methylated genomic regions into robust clinical biomarkers.

Download full-text


Available from: Andreas Waha,
  • [Show abstract] [Hide abstract]
    ABSTRACT: We propose and demonstrate the wave front correction of a vortex laser beam by using dual phase only liquid crystal spatial light modulators (LC-SLMs) and a stochastic parallel gradient descent (SPGD) algorithm. One phase only LC-SLM is used to generate vortex laser beam by loading spiral phase screen onto the wave front of input quasi-Gaussian beam. The other phase only LC-SLM under SPGD controller based on the subzone control method adaptively compensates the wave front of vortex laser beam. Numerical simulation and experimental results show that after correction, vortex doughnut like beam is focused into a beam with airy disk pattern distribution in the far field. The adaptive corrections of vortex laser beam with different optical topological charges are studied. The results show that the optical topological charge has little influence on adaptive correction. The powers in the main lobe of far field intensity distributions of vortex laser beams with different optical topological charges are all greatly improved by adaptive correction. The technique proposed in this paper can be used in optical communication, relay mirror and atmospheric turbulence correction.
    Optics Communications 03/2012; 285(6). DOI:10.1016/j.optcom.2011.09.071 · 1.45 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Die Nutzung epigenetischer Marker für die Diagnose maligner Tumoren ist unbestritten auf dem Weg in die klinische Routine. Die Möglichkeiten einer tumorspezifischen Diagnostik sind aber bei Weitem noch nicht ausgeschöpft. Dies liegt v.a. daran, dass bisherige Analysen auf Kandidaten-Gene und Promotoren fokussiert waren und weite Teile des Genoms „außen vor ließen“. Zudem wurden epigenetische und genetische Heterogenität oft nicht mit in Betracht gezogen. Umfassende neue Anstrengungen im Bereich der Tumorepigenomik unter Einbeziehung von Next-Generation-Sequenzierung (NGS) werden in naher Zukunft ein neues biologisches Verständnis schaffen. Die computergestützte Interpretation von epigenomischen Daten wird dazu führen, dass wir uns einem besseren Verständnis und der Nutzung epigenetischer Biomarker für die Tumordiagnostik immer mehr nähern. Es wird immer wichtiger werden, die gefundenen epigenetischen Marker zu kombinieren und mit Hilfe einfacher, flexibler und robuster Testverfahren in großen Kohorten zu analysieren. Hier gibt es erhebliche technische Fortschritte. Weitere interdisziplinäre Anstrengungen müssen aber noch unternommen werden, um epigenetisch basierte Tumordiagnostik in der klinischen Routine fest zu verankern. Using epigenetic markers for the diagnosis of malignant tumors is undoubtedly close to becoming part of the clinical practice. However, the possibilities for the use of epigenetic markers for tumor diagnosis are far from exhausted. So far all marker search strategies have largely focused on candidate genes and promoters while neglecting the rest of the genome. Moreover, the epigenetic and genetic heterogeneity of tumors were not taken into account. Worldwide alliances are currently being built to decipher the maps of tumor epigenomes using next generation sequencing technologies. This will generate comprehensive novel biological insights. Computer-supported interpretations of epigenomic data will lead to a more rational design of epigenetic tumor markers for diagnostic purposes. It will become increasingly important to combine epigenetic markers and to develop sensitive, flexible and robust assays for large cohort testing. Further interdisciplinary work is needed to firmly establish epigenetic diagnosis in the clinical routine. SchlüsselwörterEpigenetische Diagnose–Epigenomweite Sequenzierung–Biomarker–Epigenetische Therapie–Krebsmodelle KeywordsEpigenetic diagnosis–Next generation sequencing–Biomarker–Epigenetic therapy–Cancer models
    Der Onkologe 06/2011; 17(6):495-502. DOI:10.1007/s00761-011-2027-7 · 0.14 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Combined bisulfite restriction analysis (COBRA) is one of the most commonly used methylation quantification methods. However, it focuses on relatively few restriction enzymes. Here, we present Methyl-Typing, a web-based software that provides restriction enzyme mining data for methyl-cytosine-containing sequences following bisulfite-conversion. Gene names, accession numbers, sequences, PCR primers, and file upload are accessible for input. Promoter sequences and restriction enzymes for CpG- and GpC-containing recognition sites are retrieved. Four representative enzymes were tested successfully by COBRA on the experimental work. Therefore, the Methyl-Typing tool provides a comprehensive COBRA-restriction enzyme mining. It is freely available at
    FEBS letters 12/2009; 584(4):739-44. DOI:10.1016/j.febslet.2009.12.026 · 3.17 Impact Factor
Show more